Answers are grounded in this paper and cite their sources.
It has recently become clinically feasible to extract highly concentrated fibrinogen from the patient's own blood. In combination with commercial thrombin this fibrinogen/thrombin compound can be used as tissue adhesive, hemostatic agent and intravascular embolizer. In this presentation the authors describe a new end-to-side and side-to-side microanastomosis using this autologous "fibrin glue" (Fibrinkleber) in stead of suture material. The advantages of the new technique consist of: • Simplicity • Greatly reduced OR time • Increased patency rate • Can be done without operating microscope
No takes yet. Share an insight, caveat, or question.
Gestring et al. (1983) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: